| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |